Management Change/Compensation Form 8 K

Item 5.02. Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers.

Amendment to Rietkerk Transition, Separation and Release Agreement

On December 9, 2024, AdaptHealth Corp. (the "Company") entered into an amendment (the "Rietkerk Amendment") to its transition, separation, and release agreement with Shaw Rietkerk, the Company's Chief Business Officer, dated August 21, 2024, pursuant to which Mr. Rietkerk agreed to reduce his annual base salary from $500,000 to $125,000 commencing on January 1, 2025. The foregoing description of the Rietkerk Amendment is qualified in its entirety by reference to the full text of the Rietkerk Amendment, which is attached as Exhibit 10.1 hereto and incorporated by reference herein.